High Purity of Lutein Diester
Microbial synthesis ensures a minimal complex mix of related xanthophylls , leading to a product requiring less purification.
Lutein Ester is a highly bioavailable and stable form of the carotenoid Lutein, widely used in dietary supplements (for eye health) and as a natural colorant in the food and cosmetics industries. Traditional production via plant extraction (e.g., marigold petals) suffers from low purity in plant extraction , often yielding a mixture of Lutein, Lutein mono- and di-esters, and other xanthophylls, requiring complex and expensive chromatography for purification. Furthermore, the free Lutein intermediate exhibits poor stability against oxidation, light, and heat. Biosynthesis in an engineered microbial host offers precise control over product composition and enhanced stability.
CD Biosynsis offers a synthetic biology service focused on efficient Lutein Ester production in Escherichia coli. Our core strategy involves modification of carotenoid pathway in Escherichia coli . We genetically engineer the E. coli host by introducing and optimizing the gene cluster (CrtE, CrtB, CrtI, CrtY, CrtX, CrtL, CrtY) necessary to convert endogenous IPP precursors into Lutein. This pathway is meticulously balanced to ensure high flux toward the final Lutein molecule. This is coupled with overexpression of acyltransferase . We introduce and heavily overexpress a specific Lutein Acyltransferase enzyme (LutE or a functional homolog) designed to perform the esterification reaction. This enzyme efficiently converts the newly synthesized free Lutein into the highly stable Lutein diester (the desired form). The overexpression is controlled to maximize conversion, thereby ensuring high purity and superior stability of the final product. This integrated approach aims to deliver a high-titer, high-purity Lutein Ester product from a fast-growing microbial host, eliminating the variability and complexity associated with plant extraction.
Get a QuoteDeveloping a competitive Lutein Ester production route faces these key limitations:
A successful solution must ensure microbial synthesis of Lutein and achieve complete enzymatic conversion to the highly stable diester form.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Lutein Ester production in E. coli:
Modification of Carotenoid Pathway in E. coli
We engineer the native MEP precursor pathway and introduce the Lutein synthesis cluster (Crt genes) with balanced gene expression to eliminate bottlenecks and maximize flux to Lutein.
Overexpression of Acyltransferase
We introduce and overexpress a highly active, Lutein-specific Acyltransferase (LutE) to drive the complete, high-efficiency conversion of Lutein to the desired, stable Lutein Diester form.
Metabolite Localization Optimization
We engineer the host cell (e.g., using lipid droplet targeting ) to create an optimal cellular environment for the synthesis and accumulation of the hydrophobic Lutein and Lutein Ester.
By-product Pathway Deletion
We knock out or downregulate genes that lead to the formation of undesired carotenoid by-products (e.g., zeaxanthin) or precursors, ensuring maximum purity of the Lutein Ester.
This systematic approach is focused on rebuilding the entire pathway to ensure high microbial yield and complete product stabilization.
Our Lutein Ester engineering service is dedicated to pursuing the following production goals:
High Purity of Lutein Diester
Microbial synthesis ensures a minimal complex mix of related xanthophylls , leading to a product requiring less purification.
Superior Stability and Shelf-life
Enzymatic conversion to the diester form protects the Lutein molecule from oxidation and degradation, solving the poor stability issue.
Controllable Product Composition
Gene expression fine-tuning allows for precise control over the mono-/di-ester ratio , which is impossible with plant extraction.
High Titer from Fast-growing Host
E. coli fermentation cycles are fast and scalable, leading to higher volumetric productivity compared to slow-growing plants.
Cost-Effective Raw Materials
Utilizes inexpensive carbon sources (e.g., glucose) instead of expensive, seasonally dependent plant biomass as feedstock.
We provide a highly controlled, high-yield biosynthetic route for Lutein Ester production.
Our Lutein Ester strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and esterification completeness.
Explore the potential for a stable, high-purity Lutein Ester supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
What is the difference between Lutein and Lutein Ester?
Lutein is the free xanthophyll with two hydroxyl (OH) groups. Lutein Ester is Lutein where one or both OH groups are esterified with fatty acids (mono- or di-ester). The esterified form is less polar and significantly more stable against heat and oxidation.
How does microbial synthesis solve the purity issue?
In E. coli, we only introduce the specific genes needed to make Lutein and the Lutein Ester. This controlled pathway avoids the synthesis of many structurally similar, contaminating pigments (like Zeaxanthin or Cryptoxanthin) that naturally occur in plants, yielding a cleaner product .
What is the MEP pathway bottleneck?
The MEP (Methylerythritol Phosphate) pathway is the native bacterial route for generating IPP and DMAPP precursors. Enzymes in this pathway (e.g., DXS) are often subject to feedback inhibition. Overcoming this inhibition through genetic modification is crucial for driving high Lutein production.
Why use E. coli instead of yeast for this product?
While yeast can be used, E. coli offers faster growth rates and simpler genetics for incorporating the bacterial-origin carotenoid pathway genes. It also allows for easier control of the MEP pathway, often leading to higher initial titers of the precursor.
What is the estimated project timeline?
A project involving multi-gene pathway assembly, MEP optimization, and enzyme overexpression typically requires 20-24 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.